Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Geriatr Oncol. 2016 Feb 23;7(2):71–80. doi: 10.1016/j.jgo.2016.02.002

Table 1.

Sample baseline characteristics

Variables Wii
(n=8)
N (%) or Mean
(SD)
EXCAP
(n=6)
N (%) or Mean
(SD)
Control
(n=5)
N (%) or Mean
(SD)
p-value
Demographics
 Age 77.5 (6.7) 75.7 (9.5) 71.8 (5) 0.41
  Range 70-87 67-93 67-80
 Marital Status
  Married 6 (75.0) 3 (50.0) 4 (80.0) 0.49
  Unmarried 2 (25.0) 3 (50.0) 1 (20.0)
 Education
  HS/Some
  college 6 (75.0) 3 (50.0) 2 (40.0) 0.41
  Bachelors+ 2 (25.0) 3 (50.0) 3 (60.0)
 Work
  Working 3 (37.5) 4 (66.7) 1 (20.0) 0.28
  Not working 5 (62.5) 2 (33.3) 4 (80.0)
 Race
  White 7 (87.5) 4 (66.7) 3 (60.0) 0.49
  African
  American 1 (12.5) 2 (33.3) 2 (40.0)

Clinical
characteristics
 BMI 29.5 (4.2) 28.5 (3.5) 31.8 (4.7) 0.43
 IADL 11.1 (1.7) 11.8 (0.4) 11.4 (0.5) 0.56
 KPS 87.5 (8.9) 88.3 (13.3) 88 (16.4) 0.99
 Time on ADT (months) 67.4 (67.9) 58.7 (56.3) 60 (66.6) 0.96
 Gleason Score 7.1 (1.6) 8.0 (1) 7.6 (1.3) 0.54
 PSA 1.9 (2.9) 2.4 (3.1) 21.9 (30.2) 0.09
 Comorbidity
  0 to 1 6 (75.0) 4 (66.7) 3 (60.0) 0.96
  2 2 (25.0) 2 (33.3) 2 (40.0)
Outcomes
 SPPB 9.1 (2.0) 8.7 (2.8) 7.8 (3.4) 0.69
 Handgrip 29.1 (6.2) 33.8 (11.0) 34.7 (6.8) 0.41
 Steps per day 2999.9 (2627.9) 3593.9 (2777.1) 2625.7 (2286.1) 0.82
 Muscle Mass 49 (6.2) 56.3 (6.8) 59.4 (8.2) 0.04
 Chest press repetition
 max
59.1 (12.2) 78.8 (29.1) 72 (19.2) 0.22

Abbreviations: BMI – Body Mass Index, IADL – instrumental activities of daily living, KPS – Karnofsky Performance Status, ADT – Androgen deprivation therapy, PSA – Prostate-specific antigen, SPPB –Short physical performance battery P-values represent comparisons of covariates across study arms using ANOVA or Pearson Chi-Square tests

* Two individuals with high PSA were in the control arm with values of 44.8 and 63.5